Literature DB >> 26038399

The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2.

Nicholas J Lennemann1, Madeline Walkner1, Abigail R Berkebile1, Neil Patel1, Wendy Maury1.   

Abstract

BACKGROUND: N-linked glycosylation is a common posttranslational modification found on viral glycoproteins (GPs) and involved in promoting expression, cellular attachment, protection from proteases, and antibody evasion. The GP subunit GP2 of filoviruses contains 2 completely conserved N-linked glycosylation sites (NGSs) at N563 and N618, suggesting that they have been maintained through selective pressures.
METHODS: We assessed mutants lacking these glycans for expression and function to understand the role of these sites during Ebola virus entry.
RESULTS: Elimination of either GP2 glycan individually had a modest effect on GP expression and no impact on antibody neutralization of vesicular stomatitis virus pseudotyped with Ebola virus GP. However, loss of the N563 glycan enhanced entry by 2-fold and eliminated GP detection by a well-characterized monoclonal antibody KZ52. Loss of both sites dramatically decreased GP expression and abolished entry. Surprisingly, a GP that retained a single NGS at N563, eliminating the remaining 16 NGSs from GP1 and GP2, had detectable expression, a modest increase in entry, and pronounced sensitivity to antibody neutralization.
CONCLUSIONS: Our findings support the importance of the GP2 glycans in GP expression/structure, transduction efficiency, and antibody neutralization, particularly when N-linked glycans are also removed from GP1.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ebola virus; N-linked glycosylation; antibody neutralization; filovirus; glycan; glycoprotein; mutagenesis; virus entry

Mesh:

Substances:

Year:  2015        PMID: 26038399      PMCID: PMC4564545          DOI: 10.1093/infdis/jiv201

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.

Authors:  Jens H Kuhn; Stephan Becker; Hideki Ebihara; Thomas W Geisbert; Karl M Johnson; Yoshihiro Kawaoka; W Ian Lipkin; Ana I Negredo; Sergey V Netesov; Stuart T Nichol; Gustavo Palacios; Clarence J Peters; Antonio Tenorio; Viktor E Volchkov; Peter B Jahrling
Journal:  Arch Virol       Date:  2010-10-30       Impact factor: 2.574

2.  Structural basis for Marburg virus neutralization by a cross-reactive human antibody.

Authors:  Takao Hashiguchi; Marnie L Fusco; Zachary A Bornholdt; Jeffrey E Lee; Andrew I Flyak; Rei Matsuoka; Daisuke Kohda; Yusuke Yanagi; Michal Hammel; James E Crowe; Erica Ollmann Saphire
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein.

Authors:  Jeffrey E Lee; Marnie L Fusco; Dafna M Abelson; Ann J Hessell; Dennis R Burton; Erica Ollmann Saphire
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-10-22

5.  N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus.

Authors:  G Zimmer; I Trotz; G Herrler
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.

Authors:  Xiangguo Qiu; Judie B Alimonti; P Leno Melito; Lisa Fernando; Ute Ströher; Steven M Jones
Journal:  Clin Immunol       Date:  2011-08-31       Impact factor: 3.969

7.  Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity.

Authors:  L McGinnes; T Sergel; J Reitter; T Morrison
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

8.  A shared structural solution for neutralizing ebolaviruses.

Authors:  João M Dias; Ana I Kuehne; Dafna M Abelson; Shridhar Bale; Anthony C Wong; Peter Halfmann; Majidat A Muhammad; Marnie L Fusco; Samantha E Zak; Eugene Kang; Yoshihiro Kawaoka; Kartik Chandran; John M Dye; Erica Ollmann Saphire
Journal:  Nat Struct Mol Biol       Date:  2011-11-20       Impact factor: 15.369

Review 9.  The secret life of viral entry glycoproteins: moonlighting in immune evasion.

Authors:  Jonathan D Cook; Jeffrey E Lee
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

10.  Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.

Authors:  Nicholas J Lennemann; Bethany A Rhein; Esther Ndungo; Kartik Chandran; Xiangguo Qiu; Wendy Maury
Journal:  MBio       Date:  2014-01-28       Impact factor: 7.867

View more
  10 in total

1.  Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice.

Authors:  Nicholas J Lennemann; Andrew S Herbert; Rachel Brouillette; Bethany Rhein; Russell A Bakken; Katherine J Perschbacher; Ashley L Cooney; Catherine L Miller-Hunt; Patrick Ten Eyck; Julia Biggins; Gene Olinger; John M Dye; Wendy Maury
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function.

Authors:  Bin Wang; Yujie Wang; Dylan A Frabutt; Xihe Zhang; Xiaoyu Yao; Dan Hu; Zhuo Zhang; Chaonan Liu; Shimin Zheng; Shi-Hua Xiang; Yong-Hui Zheng
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

3.  Functional Role of N-Linked Glycosylation in Pseudorabies Virus Glycoprotein gH.

Authors:  Melina Vallbracht; Sascha Rehwaldt; Barbara G Klupp; Thomas C Mettenleiter; Walter Fuchs
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

4.  Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.

Authors:  Julia Ma; Xuexiang Zhang; Veronica Soloveva; Travis Warren; Fang Guo; Shuo Wu; Huagang Lu; Jia Guo; Qing Su; Helen Shen; Eric Solon; Mary Ann Comunale; Anand Mehta; Ju-Tao Guo; Sina Bavari; Yanming Du; Timothy M Block; Jinhong Chang
Journal:  Antiviral Res       Date:  2017-12-15       Impact factor: 5.970

5.  Initiating a watch list for Ebola virus antibody escape mutations.

Authors:  Craig R Miller; Erin L Johnson; Aran Z Burke; Kyle P Martin; Tanya A Miura; Holly A Wichman; Celeste J Brown; F Marty Ytreberg
Journal:  PeerJ       Date:  2016-02-16       Impact factor: 2.984

6.  Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model.

Authors:  Joanna L Miller; Simon G Spiro; Stuart D Dowall; Irene Taylor; Antony Rule; Dominic S Alonzi; Andrew C Sayce; Edward Wright; Emma M Bentley; Ruth Thom; Graham Hall; Raymond A Dwek; Roger Hewson; Nicole Zitzmann
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

Review 7.  Glycosylation of viral proteins: Implication in virus-host interaction and virulence.

Authors:  Tingting Feng; Jinyu Zhang; Zhiqian Chen; Wen Pan; Zhengrong Chen; Yongdong Yan; Jianfeng Dai
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

8.  Glycan shield of the ebolavirus envelope glycoprotein GP.

Authors:  Weiwei Peng; Vamseedhar Rayaprolu; Amar D Parvate; Matti F Pronker; Sean Hui; Diptiben Parekh; Kelly Shaffer; Xiaoying Yu; Erica O Saphire; Joost Snijder
Journal:  Commun Biol       Date:  2022-08-04

9.  Production and Purification of Filovirus Glycoproteins in Insect and Mammalian Cell Lines.

Authors:  Elizabeth C Clarke; Amanda L Collar; Chunyan Ye; Yíngyún Caì; Eduardo Anaya; Derek Rinaldi; Britney Martinez; Sarah Yarborough; Christine Merle; Manfred Theisen; Jiro Wada; Jens H Kuhn; Steven B Bradfute
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

Review 10.  Animal and human RNA viruses: genetic variability and ability to overcome vaccines.

Authors:  T G Villa; Ana G Abril; S Sánchez; T de Miguel; A Sánchez-Pérez
Journal:  Arch Microbiol       Date:  2020-09-28       Impact factor: 2.552

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.